Found Alternatives: How the GLP-1 Telehealth Category Compares

Last reviewed: May 12, 2026 Last updated: May 12, 2026

Written by: Jay Hastings , CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance. His work has included scaling healthcare startups, leading CLIA lab integrations, and helping expand consumer access to precision health tools.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

Weighing Found against the wider field of GLP-1 telehealth programs is one of the more common ways shoppers begin. This independent review maps that field for readers already considering Found alternatives. Explore the full Peptides & GLP-1 education library.

PlexusDx published this as editorial analysis. We hold no commercial relationship with Found or its parent company, and nothing here is an affiliate placement or paid endorsement.

Found sits inside a crowded category of subscription weight-management services. Below we outline how the category is built, what genuinely separates one option from the next, and the one variable that stays constant across every alternative. Balanced framing, not a purchase recommendation. Current as of April 2026.

Why shoppers look past a single program

Most people who search for alternatives are not unhappy with one brand specifically; they are trying to understand a category that markets itself in nearly identical language. Nearly every GLP-1 telehealth service promises convenience, licensed clinicians, and home delivery, which makes the differences hard to see from the outside. Comparison shopping is a reasonable response to that sameness.

The category at a glance

The programs competing for the same searches share a spine: remote clinical review, a prescription, and pharmacy fulfillment. What moves around that spine is the compound offered, whether the medication is an FDA-approved brand product or a compounded preparation from a 503A pharmacy, and how the recurring relationship is billed.

How Found is put together

Intake and clinical review

A prospective patient submits weight, medical history, and a medication list, and a licensed clinician decides whether GLP-1 therapy is appropriate. See Found's own website for the current intake flow.

Prescription and routing

If eligible, the clinician writes a prescription that is routed either to a retail pharmacy for a branded product or to a 503A compounding pharmacy for compounded semaglutide or tirzepatide.

Ongoing follow-up

Continued telehealth touchpoints support dose titration and side-effect management over time.

What actually differs between alternatives

When you line these programs up, the meaningful contrasts are provider type (physician versus nurse practitioner or physician assistant), pharmacy partner (retail brand versus compounded), the specific compound class dispensed, and subscription structure. The underlying pharmacology, however, is category-wide: GLP-1 receptor agonists such as semaglutide, liraglutide, and dulaglutide, plus the GIP/GLP-1 dual agonist tirzepatide. Trial evidence including the STEP program (semaglutide, The New England Journal of Medicine, 2021) and SURMOUNT (tirzepatide, NEJM 2022), along with SURMOUNT-OSA for obstructive sleep apnea (NEJM 2024), describes the compounds, not any one brand. Populations and endpoints vary, and individual outcomes vary.

The variable every alternative leaves out

No program in this category, Found included, addresses the genetic architecture underneath a GLP-1 response. Variants in GLP1R, the gene encoding the receptor every GLP-1 compound targets, and in FTO, the fat-mass and obesity-associated gene, describe the metabolic terrain a clinician is prescribing into. These markers are pathway-level context, not a response prediction. That is where the PlexusDx approach diverges. Before beginning any GLP-1 protocol, the Precision Peptide Genetic Test reads 14 pathways, 49 peptides, 150+ genetic insights, including FTO and GLP1R variants that shape baseline appetite-regulation and energy-balance biology. PlexusDx also offers semaglutide and tirzepatide directly through its Weight Management Protocols, so the genetic context and the protocol sit side by side rather than apart.

No affiliation: PlexusDx is independent of Found and holds no commercial relationship with the programs discussed here.

More from the PlexusDx library: What Is GLP 1, GLP 1 What Is, GLP 1 Receptor Agonist, and GLP 1 Drugs.

Disclaimer: This comparison is educational. PlexusDx is not affiliated with Found and reviews approaches across the GLP-1 telehealth space, including its own Weight Management Protocols. The Precision Peptide Genetic Test examines how your genes influence peptide-related pathways and does not predict response to any specific medication. Talk with a qualified healthcare provider before starting any peptide protocol.

Frequently Asked Questions

How should I compare Found with other GLP-1 programs?

Look past the marketing language and compare the concrete pieces: which compound is offered, whether it is branded or compounded through a 503A pharmacy, the clinician type, and the billing structure. Those differences matter more than slogans that sound identical across nearly every alternative in the category.

Is a compounded program a lesser alternative to a branded one?

Not inherently. Compounded semaglutide and tirzepatide come from state-licensed 503A pharmacies and follow a legitimate pathway, while branded products come from retail pharmacies. They are different routes rather than better-or-worse tiers. Verify licensure and pharmacy credentials on any program's own site before deciding.

Does PlexusDx replace a telehealth alternative?

PlexusDx offers its own Weight Management Protocols with semaglutide and tirzepatide, paired with genetic context that pure telehealth alternatives do not include. Whether it fits depends on whether you want that upstream pathway insight alongside the medication rather than the medication on its own.

Where does the genetic test fit when comparing options?

It sits upstream of the comparison entirely. The test reads pathway-level variants such as FTO and GLP1R that apply no matter which program eventually prescribes a compound, so it informs the conversation with your provider rather than picking one alternative over another.

Continue exploring the PlexusDx Education Hub. Browse Peptides & GLP-1 education.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance. References are included at the end of the article when scientific, medical, or health-related claims are discussed.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.